Immunogenicity and Safety of vYF, a Yellow Fever Vaccine — A Phase 2 Trial

Emmanuel Feroldi

Sanofi, Lyon, France

Mark J. Mulligan

NYU Langone Vaccine Center, Division of Infectious Diseases and Immunology, Department of Medicine, NYU Grossman School of Medicine, New York

Kawsar R. Talaat

Chen Sabrina Tan

Center for Virology and Vaccine Research, Division of Infectious Diseases, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston

Kristopher Paolino

SUNY Upstate Medical University, Syracuse, NY

Srilatha Edupuganti

Emory Vaccine Center, Emory University School of Medicine

Matthew H. Collins

Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta

Sarah L. George

Saint Louis University Center for Vaccine Development, St. Louis

Matthew Davis

Department of Chemistry and Centre for Radiochemistry Research, The University of Manchester, Oxford Road, Manchester M13 9PL, U.K.

Brandon Essink

Meridian Clinical Research, Omaha, NE

Robert Jeanfreau

MedPharmics, Metairie, LA

James Peterson

J. Lewis Research, Foothill Family Clinic, Salt Lake City

David Fried

Velocity Clinical Research–Providence, East Greenwich, RI

Ada-Maria Minutello

Sanofi, Lyon, France

Sandrine Orlando

Sanofi, Lyon, France

Joanna Korejwo

Sanofi, Lyon, France

Andrey Rojas

Sanofi, Bogotá, Colombia

Marine Dufournet

Sanofi, Lyon, France

Tifany Machabert

Sanofi, Lyon, France

Louis Devlin

Sanofi, Swiftwater, PA

Carina Frago

Sanofi, Singapore